Health care industry

FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)
October 28, 2020 - 1:09 pm
WASHINGTON — The U.S. government has agreed to buy initial doses of an experimental COVID-19 antibody drug from Eli Lilly that patients could receive if federal regulators allow it on an emergency basis. Lilly has asked the U.S. Food and Drug Administration to allow use of the drug in mild to...
Read More
Pat Austin takes COVID-19 swabs in for testing at the state drive-thru testing location UTEP Monday, Oct. 26, 2020 in El Paso, Texas. The testing drive-thru site is open from 9 a.m. to 4 p.m. Monday, Wednesday and Friday. (Briana Sanchez/The El Paso Times via AP)
October 27, 2020 - 7:07 pm
A record surge in coronavirus cases is pushing hospitals to the brink in the border cities of El Paso and Ciudad Juarez, confronting health officials in Texas and Mexico with twin disasters in the tightly knit metropolitan area of 3 million people. Health officials are blaming the spike on family...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Surging sales of cancer medicines and reduced spending helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter. The drugmaker on Friday, July 31, 2020, increased its financial forecast for the year, all while it’s investing in development of two experimental vaccines and a possible treatment for COVID-19. (AP Photo/Seth Wenig, File)
October 27, 2020 - 3:08 pm
Drugmaker Merck, bouncing back from a $1.6 billion hit from the coronavirus pandemic in the second quarter, boosted its third-quarter profit by 55% and blew past Wall Street expectations. The strong result was due to sales slightly higher than a year ago, plus restrained spending. The Kenilworth,...
Read More
FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)
October 27, 2020 - 8:43 am
INDIANAPOLIS (AP) — Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday it remains confident that its drug may stop COVID from developing in other patients. Researchers are still studying the...
Read More
Pfizer signs are seen out front of the Pfizer Research & Development Laboratories Wednesday, July 22, 2020, in Groton, Conn. Pfizer on Tuesday, July 28, reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)
October 27, 2020 - 7:49 am
Drugmaker Pfizer saw its third-quarter profit plunge 71%, mainly due to an $8.1 billion gain a year earlier from selling its consumer health care business to a GlaxoSmithKline joint venture, but managed to top Wall Street expectations. Meanwhile, the New York-based company on Tuesday said...
Read More
A woman, wearing a face mask to prevent the spread of the coronavirus COVID-19, walks along Cinquantenaire park in an autumn day in Brussels, Friday, Oct. 23, 2020. Belgian Prime Minister Alexander De Croo stopped short Friday of imposing another full lockdown, as the country did in March, but introduced a series of new restrictive measures as the number of COVID-19 related hospital admissions and deaths continue to soar. (AP Photo/Francisco Seco)
October 26, 2020 - 8:02 am
BRUSSELS (AP) — Authorities warned Monday that Belgium faces a pivotal week in its struggle to limit the spread of the coronavirus, as a series of new restrictions took effect in one of the European countries hardest hit by the pandemic. Almost 12,500 new cases are being reported on average every...
Read More
FILE - In this Oct. 21, 2020, file photo, Exam Corp Lab employee, right, wears a mask as she talks with a patient lined up for COVID-19 testing in Niles, Ill. The United States is approaching a record for the number of new daily coronavirus cases in the latest ominous sign about the disease's grip on the nation. (AP Photo/Nam Y. Huh, File)
October 23, 2020 - 8:20 pm
BOISE, Idaho (AP) — The United States is approaching a record for the number of new daily coronavirus cases in the latest ominous sign about the disease’s grip on the nation, as states from Connecticut to the Rocky Mountain West reel under the surge. The impact is being felt in every section of the...
Read More
FILE - In this Wednesday, June 24, 2020 file photo, a volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. On Friday, Oct. 23, 2020, AstraZeneca Inc. announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Siphiwe Sibeko/Pool via AP)
October 23, 2020 - 6:30 pm
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study...
Read More
FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. The U.S. Food and Drug Administration will hold a meeting to discuss the process of approving COVID-19 vaccines. (AP Photo/Hans Pennink, File)
October 22, 2020 - 8:26 pm
WASHINGTON (AP) — Scientific advisers told U.S. regulators Thursday they’re concerned that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work. The Food and Drug Administration may have to decide by year's...
Read More
Medical Assistant Casey Garrison inputs patient information on a form at the drive-thru coronavirus testing at a respiratory clinic in Casper, Wyo., Friday, Oct. 9, 2020. Wyoming health officials reported the number of people hospitalized with the virus has increased to the highest since March.(Cayla Nimmo/The Casper Star-Tribune via AP)
October 21, 2020 - 6:26 pm
BOISE, Idaho (AP) — Hospitals across the United States are starting to buckle from a resurgence of COVID-19 cases, with several states setting records for the number of people hospitalized and leaders scrambling to find extra beds and staff. New highs in cases have been reported in states big and...
Read More

Pages